JG
COLL icon

Jefferies Group’s Collegium Pharmaceutical COLL Stock Holding History

Jefferies Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-27,000
Closed -$498K – 2299
2017
Q4 		$498K Buy
+27,000
New +$387K ﹤0.01% 1729

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jefferies Group's COLL Position: Q3 2022 in Review

Jefferies Group opened a new position in Collegium Pharmaceutical (COLL) in Q3 2022: 21,250 shares worth $340K. The stake represents ﹤0.01% of the portfolio and ranks #1182 among its holdings. This is a return to the name: Jefferies Group previously reported a position in COLL as recently as Q4 2021.

Jefferies Group first reported a position in COLL in Q4 2016 and has held it in 9 quarters since. The position peaked at $3.01M in Q4 2021. 168 funds tracked by Wall St. Rank hold COLL as of Q3 2022.

  • Jefferies Group held 21,250 shares of Collegium Pharmaceutical worth $340K as of Q3 2022.
  • Collegium Pharmaceutical was a new Jefferies Group position in Q3 2022.
  • Collegium Pharmaceutical made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1182 holding.
  • Jefferies Group first reported a position in Collegium Pharmaceutical in Q4 2016 and has held it in 9 quarters since.
  • Jefferies Group's Collegium Pharmaceutical position peaked at $3.01M in Q4 2021.
  • 168 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.